Folylpolyglutamate Synthetase Gene Transcription is Regulated by a Multiprotein Complex that Binds the TEL-AML1 Fusion in Acute Lymphoblastic Leukemia

被引:10
|
作者
Leclerc, Guy J. [1 ]
Sanderson, Christopher [1 ]
Hunger, Stephen [2 ]
Devidas, Meenakshi [3 ,4 ]
Barredo, Julio C. [1 ,5 ,6 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Pediat Hematol & Oncol, Miami, FL 33101 USA
[2] Childrens Hosp, Denver, CO 80218 USA
[3] Univ Florida, Coll Med, Childrens Oncol Grp, Gainesville, FL USA
[4] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA
[5] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
[6] Univ Miami, Miller Sch Med, UM Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA
关键词
FPGS; TEL-AML1; Rb/E2F; Chromatin remodeling; ALL; leukemia; HDAC1; methotrexate; METHOTREXATE POLYGLUTAMATES; B-LINEAGE; T-LINEAGE; EXPRESSION; CELL; ACCUMULATION; TEL; CHEMOTHERAPY; COMBINATION; MECHANISMS;
D O I
10.1016/j.leukres.2010.05.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute Lymphoblastic Leukemia (ALL) non-random fusions influence clinical outcome and alter the accumulation of MTX-PGs in vivo. Analysis of primary ALL samples uncovered subtype-specific patterns of folate gene expression. Using an FPGS-luciferase reporter gene assay, we determined that E2A-PBX1 and TEL-AML1 expression decreased FPGS transcription. ChIP assays uncovered HDAC1, AML1, mSin3A, E2F, and Rb interactions with the FPGS promoter region. We demonstrate that FPGS expression is epigenetically regulated through binding of selected ALL fusions to a multiprotein complex, which also controls the cell cycle dependence of FPGS expression. This study provides insights into the pharmacogenomics of MTX in ALL subtypes. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1601 / 1609
页数:9
相关论文
共 50 条
  • [21] TEL-AML1 gene fusion is a common occurrence in human childhood B lineage acute lymphoblastic leukemia.
    Romana, SP
    Poirel, H
    Macintyre, EA
    Berger, R
    Bernard, OA
    BLOOD, 1995, 86 (10) : 3096 - 3096
  • [22] Low frequency of TEL-AML1 fusion gene in childhood B lineage acute lymphoblastic leukemia of Tunisian patients
    Menif, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 523 - 523
  • [23] Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia
    Wiemels, JL
    Alexander, FE
    Cazzaniga, G
    Biondi, A
    Mayer, SP
    Greaves, M
    GENES CHROMOSOMES & CANCER, 2000, 29 (03): : 219 - 228
  • [24] TEL-AML1 transgenic zebrafish model of acute lymphoblastic leukemia (ALL)
    Sabaawy, HE
    Azuma, M
    Embree, L
    Starost, MF
    Hickstein, DD
    BLOOD, 2005, 106 (11) : 34A - 34A
  • [25] Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia
    Kustanovich, AM
    Belevtsev, MV
    Stasevich, IV
    Savitskaya, TV
    Jutzkevich, RI
    Savva, NN
    Aleinikova, OV
    LEUKEMIA, 2006, 20 (01) : 165 - 167
  • [26] Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia
    A M Kustanovich
    M V Belevtsev
    I V Stasevich
    T V Savitskaya
    R I Jutzkevich
    N N Savva
    O V Aleinikova
    Leukemia, 2006, 20 : 165 - 167
  • [27] Significance of the TEL-AML1 fusion gene in childhood AML
    JE Rubnitz
    JR Downing
    C-H Pui
    Leukemia, 1999, 13 : 1470 - 1471
  • [28] TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia
    Pine, SR
    Wiemels, JL
    Jayabose, S
    Sandoval, C
    LEUKEMIA RESEARCH, 2003, 27 (02) : 155 - 164
  • [29] Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia
    Ford, AM
    Bennett, CA
    Price, CM
    Bruin, MCA
    Van Wering, ER
    Greaves, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4584 - 4588
  • [30] Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia
    Uckun, FM
    Pallisgaard, N
    Hokland, P
    Navara, C
    Narla, R
    Gaynon, PS
    Sather, H
    Heerema, N
    LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) : 41 - 56